Effects of retinoid X receptor-selective ligands on proliferation of prostate cancer cells

Prostate

Volumn 32, Issue 2, 1997, Pages 115-121

  De Vos, Sven ^a   Dawson, Marcia I ^b   Holden, Stuart ^a   Le, Thu ^a   Wang, Alexander ^a   Cho, Steve K ^a   Chen, Dan Lin ^a   Koeffler, H Phillip ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b SRI INTERNATIONAL   (United States)

Author keywords

Prostate cancer; Retinoid; RXR

Indexed keywords

4 [2 METHYL 1 (5,6,7,8 TETRAHYDRO 5,5,8,8 TETRAMETHYL 2 NAPHTHYL) 1 PROPENYL]BENZOIC ACID; ALITRETINOIN; DIMER; LIGAND; RETINOIC ACID; RETINOIC ACID RECEPTOR; RETINOID; RETINOID X RECEPTOR; TRANSCRIPTION FACTOR AP 1;

ARTICLE; CANCER CELL CULTURE; CELL PROLIFERATION; CONTROLLED STUDY; DRUG SELECTIVITY; GROWTH INHIBITION; HUMAN; HUMAN CELL; LEUKEMIA CELL; PRIORITY JOURNAL; PROSTATE CANCER;

ANTINEOPLASTIC AGENTS; CELL DIVISION; DIMERIZATION; HUMANS; KINETICS; LEUKEMIA, MYELOID; MALE; MOLECULAR STRUCTURE; PROSTATIC NEOPLASMS; RECEPTORS, RETINOIC ACID; RETINOID X RECEPTORS; RETINOIDS; STRUCTURE-ACTIVITY RELATIONSHIP; TRANSCRIPTION FACTOR AP-1; TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC; TRETINOIN; TUMOR CELLS, CULTURED;

EID: 0031001222     PISSN: 02704137     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0045(19970701)32:2<115::AID-PROS6>3.0.CO;2-L     Document Type: Article

References (41)

1. Boring CC, Squires TS, Tong T: Cancer statistics, 1991. CA 41: 19-36, 1991.
2. Carter HB, Coffey DS: Prostate cancer: The magnitude of the problem in the United States. In Coffey DS, Resnick MI, Dorr FA, Karr JP (eds): "A Multidisciplinary Analysis of Controversies in the Management of Prostate Cancer." New York: Plenum Publishing Corp., 1988:1-7.
3. Lotan R: Effect of vitamin A and its analogs (retinoids) on normal and neoplastic cells. Biochem Biophys Acta 605:33-91, 1980.
4. Strickland S, Mahdavi V: The induction of differentiation in teratocarcinoma stem cells by retinoic acid. Cell 15:393-403, 1978.
5. Huang ME, Ye YC, Chen SR, Chai JR, Lu JX, Zhoa L, Gu HT, Wang ZY: Use of all-trans-retinoic acid in the treatment of acute promyelocytic leukemia. Blood 72:567-572, 1988.
6. Castaigne S, Chomienne C, Daniel MT, Bollarini P, Berger R, Fenaux P, Degos L: All-trans-retinoic acid as a differentiation therapy for acute promyelocytic leukemia. I. Clinical results. Blood 76:1704-1709, 1990.
7. Warrell RP Jr, Frankel SR, Miller WH Jr, Sheinberg DA, Itri LM, Hittelman WN, Vyas R, Andreeff MS, Tafuri A, Jakubowski A, Gabrilove J, Gordon MS, Dimitrovsky E: Differentiation therapy of acute promyelocytic leukemia with tretinoin (all-transretinoic acid). N Engl J Med 324:1385-1393, 1991.
8. Chen ZX, Xue YQ, Zhang R, Tao RF, Xia XM, Li C, Wang W, Zu WY, Yao XZ, Ling BJ: A clinical and experimental study on all-trans-retinoic acid-treated acute promyelocytic patients. Blood 78:1413-1419, 1991.
9. Vokes EE, Weichselbaum RR, Lippman SM, Hong WH: Head and neck cancer. N Engl J Med 328:184-194, 1993.
10. Hsing AW, Comstock GW, Abbey H, Polk BF: Serologic precursors of cancer. Retinoids, carotenoids, and tocopherol and risk of prostate cancer. JNCI 82:941-946, 1990.
11. Reichman ME, Hayes RB, Ziegler RG, Schatzkin A, Taylor PR, Fraumeni JF: Serum vitamin A and subsequent development of prostate cancer in the first National Health and Nutrition Examination Survey Epidemiologic Follow-up Study. Cancer Res 50:2311-2315, 1990.
12. Dahiya R, Boyle B, Park HD, Kurhanewicz J, Macdonald JM, Narayan P: 13-cis-retinoic acid-mediated growth inhibition of DU-145 human prostate cancer cells. Biochem Mol Biol Int 32: 1-12, 1994.
13. Dahiya R, Park HD, Cusick J, Vessella RL, Fournier G, Narayan P: Inhibition of tumorigenic potential and prostate-specific antigen expression in LNCaP human prostate cancer cell line by 13-cis-retinoic acid. Int J Cancer 59:126-132, 1994.
14. Lasnitzky I, Goodman DS: Inhibition of the effects of methyl-cholanthrene on mouse prostate in organ cultures by vitamin A and its analogs. Cancer Res 34:1564-1571, 1974.
15. Chopra DP, Wilkoff LJ: Activity of retinoids against benzo(A)-pyrene-induced hyperplasia in mouse prostate organ cultures. Eur J Cancer 15:1417-1423, 1979.
16. Pollard M, Luckert PH, Sporn MB: Prevention of primary prostate cancer in Lobund-Wistar rats by 4-hydroxyphenylretin-amide. Cancer Res 51:3610-3621, 1991.
17. Slawin K, Kadmon D, Park SH, Scardino PT, Anzano M, Sporn MB, Thompson TC: Dietary fenretinide, a synthetic retinoid, decreases the tumor incidence and the tumor mass of ras + myc-induced carcinomas in the mouse prostate reconstitution model system. Cancer Res 53:4461-4465, 1993.
18. Edward M: Effects of retinoids on tumor invasion and metastasis. Pathobiology 60:271-277, 1992.
19. Giguere V, Ong ES, Segui P, Evans RM: Identification of a receptor for the morphogen retinoic acid. Nature 330:624-629, 1987.
20. Petkovick M, Brand NJ, Krust A, Chambon P: A human retinoic acid receptor which belongs to the family of nuclear receptors. Nature 330:444-450, 1987.
21. Mangelsdorf DJ, Ong ES, Dyck JA, Evans RM: A nuclear receptor that identifies a novel retinoic acid response pathway. Nature 345:224-229, 1990.
22. Evans RM: The steroid and thyroid receptor superfamily. Science 240:889-895, 1988.
23. Lotan R, Clifford JL: Nuclear receptors for retinoids: Mediators of retinoid effects on normal and malignant cells. Biomed Pharmacother 45:145-156, 1991.
24. Levin AA, Sturzenbecker LJ, Kazmer S, Bosakowski M, Lovey A, Grippo JF: 9-cis retinoic acid stereoisomer binds and activates the nuclear receptor RXRa. Nature 355:359-361, 1992.
25. Heyman RA, Mangelsdorf DJ, Dick JA, Stein RB, Eichele G, Evans RM, Thaller C: 9-cis retinoic acid is a high affinity ligand for the retinoid X receptor. Cell 68:397-406, 1992.
26. Leid M, Kastner P, Lyons R, Nakshatri H, Saunders M, Zacharewski, Chen JY, Staub A, Garnier JM, Mader S, Chambon P: Purification, cloning, and RXR identity of the Hela cell factor with which RAR and TR heterodimerizes to bind target sequences efficiently. Cell 68:377-395, 1992.
27. 3 signalling. Nature 355:446-449, 1992.
28. Marks MS, Hallenbeck PL, Nagata T, Segars JM, Appella E, Nikodem VM, Ozato K: H-2RIIBP (RXR β) heterodimerization provides a mechanism for combinational diversity in the regulation of retinoic acid and thyroid hormone responsive genes. EMBO J 11:1419-1435, 1992.
29. Yu VC, Delsert C, Anderson B, Holloway JM, Devary OV, Naar AM, Kim SY, Boutin J-M, Glass CK, Rosenfeld MG: RXRβ: A coregulator that enhances binding of retinoic acid, thyroid hormone, and vitamin D receptors to their cognate response elements. Cell 67:1251-1266, 1991.
30. Zhang XK, Hoffmann B, Tran PB, Graupner G, Pfahl M: Retinoid X receptor is an auxiliary protein for thyroid hormone and retinoic acid receptors. Nature 355:441-146, 1992.
31. Mangelsdorf DJ, Thummel C, Beato M, Herrlich P, Schutz G, Umesono K, Blumberg B, Kastner P, Mark M, Chambon P, Evans RM: The nuclear receptor superfamily: The second decade. Cell 83:835-839, 1995.
32. Zhang XK, Lehmann B, Hoffmann B, Dawson MI, Cameron J, Graupner G, Hertmann T, Tran P, Pfahl M: Homodimer formation of retinoid X receptor induced by 9-cis retinoic acid. Nature 358:587-591, 1992.
33. Fanjul A, Dawson MI, Hobbs PD, Jong L, Cameron JF, Harley E, Graupner G, Lu XP, Pfahl M: A new class of retinoids with selective inhibition of AP-1 inhibits proliferation. Nature 372: 107-110, 1994.
34. Lehmann JM, Jong L, Fanjul A, Cameron JF, Lu XP, Haefner P, Dawson MI, Pfahl M: Retinoids selective for retinoid X receptor response pathways. Science 258:1944-1946, 1992.
35. 3 analogs on clonal proliferation of human prostate cancer cell lines. Prostate 31:77-83, 1997.
36. Sakashita A, Kizaki M, Pakkala S, Schiller G, Tsuruoka N, Tanosaki R, Cameron JF, Dawson MI, Koeffler HP: 9-cis retinoic acid: Effects on normal and leukemic hematopoiesis in vitro. Blood 81:1009-1016, 1993.
37. Kizaki M, Ikeda Y, Tanosaki R, Nakajima H, Morikawa M, Sakashita A, Koeffler HP: Effects of novel retinoic acid compound, 9-cis retinoic acid, on proliferation, differentiation, and expression of retinoic acid receptor (RAR)-α and retinoid X receptor (RXR)-α RNA by HL-60 cells. Blood 82:3592-3599, 1993.
38. Kizaki M, Dawson MI, Heyman R, Elstner E, Morosetti R, Pakkala S, Chen D, Ueno H, Chao W, Morikawa M, Ikeda Y, Heber D, Pfahl M, Koeffler HP: Effects of novel retinoid X receptor (RXR) selective ligands on myeloid leukemic differentiation and proliferation in vitro. Blood 87:1977-1984, 1996.
39. Dawson MI, Elstner E, Kizaki M, Chen DL, Pakkala S, Kerner B, Koeffler HP: Myeloid differentiation mediated through retinoic acid receptor/retinoic X receptor (RXR) not RXR/RXR pathway. Blood 84:446-152, 1994.
40. Naby L, Thomazy VA, Shipley GL, Fesus L, Lamph V, Heyman RB, Chandraracna RA, Davies PJ: Activation of retinoid X receptors induces apoptosis in HL-60 cell lines. Mol Cell Biol 15: 3548-3551, 1995.
41. Dawson MI, Chao WR, Pine P, Jong L, Hobbs PD, Rudd CK, Quick TC, Niles RM, Zhang XK, Lombardo A: Correlation of retinoid binding affinity to retinoic acid receptor alpha with retinoid inhibition of growth of estrogen receptor-positive MCF-7 mammary carcinoma cells. Cancer Res 55:4446-4451, 1995.